VeriMomHamilelikte valproic acid kullanmaktan kaçınmalı mıyım? | VeriMom
Valproic acid is a well‑documented human teratogen (increased risk of neural tube and other major malformations and adverse neurodevelopmental outcomes) and is reported with H360 (may damage fertility or the unborn child) in ECHA/registration/SDS sources, which per your calibration maps to h=3. Mechanistically VPA is a histone deacetylase (HDAC) inhibitor with well‑characterised effects on gene expression and placental/embryonic development; placental effects and placental transfer have been reported. Topical cosmetic use would likely give low but measurable systemic exposure compared with therapeutic dosing (so e=1 for pregnancy). (Sources: PubMed systematic reviews and clinical teratology literature; ECHA registration/SDS showing H360; mechanistic reviews on HDAC inhibition).
ECHA regulatory hazard statements
- •H360
- •H362
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- valproic acid hamilelikte güvenli mi?
- Valproic acid is a well‑documented human teratogen (increased risk of neural tube and other major malformations and adverse neurodevelopmental outcomes) and is reported with H360 (may damage fertility or the unborn child) in ECHA/registration/SDS sources, which per your calibration maps to h=3. Mechanistically VPA is a histone deacetylase (HDAC) inhibitor with well‑characterised effects on gene expression and placental/embryonic development; placental effects and placental transfer have been reported. Topical cosmetic use would likely give low but measurable systemic exposure compared with therapeutic dosing (so e=1 for pregnancy). (Sources: PubMed systematic reviews and clinical teratology literature; ECHA registration/SDS showing H360; mechanistic reviews on HDAC inhibition).
- valproic acid emzirirken güvenli mi?
- Valproic acid is listed with H362 (may cause harm to breast‑fed children) in ECHA/SDS documents and transfers into breast milk in clinical/toxicology literature; the mechanistic actions that produce developmental neurotoxicity are the same basis for concern. For a cosmetic topical route maternal systemic levels would usually be low, so exposure via breastmilk from cosmetic use is expected to be low but measurable (e=1).
- valproic acid bebek cildi için güvenli mi?
- Hazard remains high because VPA is a confirmed human developmental/teratogenic agent and H360/H362 are reported; mechanism (HDAC inhibition, disruption of developmental signalling) is well characterised. If VPA were present on infant skin (0–3 yrs) dermal absorption is more significant than in adults; per your rules increase exposure by +1 when measurable — cosmetic topical adult e=1 becomes baby e=2. There are no infant‑topical specific safety data showing safe use on baby skin.
- VeriMom valproic acid nasıl puanlıyor?
- VeriMom valproic acid'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 13/100 (yüksek risk) olarak puanlar.
- Hamilelikte valproic acid yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.